PMID- 25639690 OWN - NLM STAT- MEDLINE DCOM- 20160212 LR - 20181222 IS - 1532-8414 (Electronic) IS - 1071-9164 (Linking) VI - 21 IP - 5 DP - 2015 May TI - Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses. PG - 391-397 LID - S1071-9164(15)00024-X [pii] LID - 10.1016/j.cardfail.2015.01.004 [doi] AB - BACKGROUND: Fulminant myocarditis (FM) is a rare but life-threatening disease. Intravenous immunoglobulin (IVIG) is not recommended for acute or chronic myocarditis in Western nations owing to the lack of rigorous evidence, but it is widely used in other countries, including Japan. This nationwide retrospective cohort study focused on evaluating the effect of IVIG in FM patients. METHODS AND RESULTS: Using the Diagnosis Procedure Combination database in Japan, we identified 603 FM patients aged >/=16 years who received mechanical circulatory support within 7 days after admission. We performed propensity score analyses to compare the in-hospital mortality and total costs between IVIG users (n = 220; 36.5%) and nonusers (n = 383; 63.5%). Among propensity score-matched patients (164 pairs), there was no significant difference in in-hospital mortality between IVIG users and nonusers (36.6% vs 37.2%; P = .909). A multivariable logistic regression analysis showed no significant association between IVIG use and in-hospital mortality (adjusted odds ratio 0.91; 95% confidence interval 0.52 to 1.58; P = .733). The median total costs were significantly higher for IVIG users than for nonusers (US $44,226 vs $33,280; P < .001). CONCLUSION: IVIG for FM was not significantly associated with a decrease in in-hospital mortality. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Isogai, Toshiaki AU - Isogai T AD - Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan; Department of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan. Electronic address: toisogai-circ@umin.ac.jp. FAU - Yasunaga, Hideo AU - Yasunaga H AD - Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. FAU - Matsui, Hiroki AU - Matsui H AD - Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. FAU - Tanaka, Hiroyuki AU - Tanaka H AD - Department of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan. FAU - Horiguchi, Hiromasa AU - Horiguchi H AD - Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Tokyo, Japan. FAU - Fushimi, Kiyohide AU - Fushimi K AD - Department of Health Policy and Informatics, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150130 PL - United States TA - J Card Fail JT - Journal of cardiac failure JID - 9442138 RN - 0 (Immunoglobulins, Intravenous) RN - 0 (Immunologic Factors) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Cohort Studies MH - Databases, Factual/trends MH - Female MH - Hospital Mortality/*trends MH - Humans MH - Immunoglobulins, Intravenous/*therapeutic use MH - Immunologic Factors/*therapeutic use MH - Japan/epidemiology MH - Male MH - Middle Aged MH - Myocarditis/*drug therapy/epidemiology/*mortality MH - Propensity Score MH - Retrospective Studies MH - Treatment Outcome MH - Young Adult OTO - NOTNLM OT - Fulminant myocarditis OT - immunoglobulin OT - mortality OT - propensity score analysis EDAT- 2015/02/03 06:00 MHDA- 2016/02/13 06:00 CRDT- 2015/02/03 06:00 PHST- 2014/07/26 00:00 [received] PHST- 2014/12/31 00:00 [revised] PHST- 2015/01/23 00:00 [accepted] PHST- 2015/02/03 06:00 [entrez] PHST- 2015/02/03 06:00 [pubmed] PHST- 2016/02/13 06:00 [medline] AID - S1071-9164(15)00024-X [pii] AID - 10.1016/j.cardfail.2015.01.004 [doi] PST - ppublish SO - J Card Fail. 2015 May;21(5):391-397. doi: 10.1016/j.cardfail.2015.01.004. Epub 2015 Jan 30.